Introduction

Expansion of CD4 T-cells that express Foxp3 is a feature of active tuberculosis (TB). High numbers of Foxp3
+ CD4 T-cells with a T-regulatory functional profile in blood [1, 2] and at sites of Mycobacterium tuberculosis (MTB) infection [3, 4] have been documented. The basis of expansion of T-reg at sites of dual HIV-1 and TB (HIV/TB) co-infection has been studied more recently. Expression of Foxp3, a molecular signature marker of T-reg [5] , among pleural fluid mononuclear cells (PFMC) at sites of HIV/TB co-infection was significantly higher than that in autologous PBMC [6] . Other has reported expression of CD39 in addition to Foxp3 as a marker of T-reg in TB [7] . Pleural sites of active HIV/TB infection are prominent in HIV-1 activity as compared to that found systemically [8] , and currently activated CD4 T-cells are believed to be the predominant source of HIV-1 in situ [9] . Whether T-reg contribute to productive HIV-1 infection at sites of HIV/TB is not known.
Foxp3 expression is necessary in establishing the regulatory T-cell lineage both for thymus-derived natural (n) T-reg, and induced (i) T-reg derived from naive CD4 T-cells outside of the thymus (Reviewed in [10] ). Expression of Foxp3 in iT-reg is under control by epigenetic regulatory elements [11] . In peripheral lymphoid tissues, transforming growth factor beta (TGF-β) is critical to induction of expression of Foxp3 in T-cell receptor (TCR) activated naïve CD4 T-cells [12, 13] . Whereas induction of iT-reg requires TGF-β alone,expansion of TGF-β induced iT-reg is dependent on the NFкb/c-Rel [14] and/or IL-2/Stat5 signaling [15] pathways. At sites of pleural TB, TGF-β and pro-inflammatory cytokines (IL-8, IL-6, and IFN-g), but not IL-2, are abundant [6] . Further, Foxp3 mRNA expression in PFMC correlated with levels of IL-6, IL-8 and TGF-β in pleural fluid [6] , suggesting that continuous TCR activation through cytokines in the cellular micro milieu at sites of pleural HIV/TB infection may be conducive to stabilization of Foxp3 expression in PFMC T-reg.
T-reg have been found to be targets of HIV-1 infection among
Abstract
Background: Regulatory T-cells (T-reg) are expanded during active tuberculosis (TB) regardless of HIV-1-infection, particularly at sites of M. tuberculosis infection. In HIV-1 disease, T-reg are targeted by HIV-1 infection. However, whether they contribute to promotion of HIV-1 infection at sites of HIV/TB is unknown.
Methods:
Pleural fluid mononuclear cells (PFMC) from HIV/TB patients with pleural TB were characterized by immunostaining and FACS analysis for surface markers CD4, CD127, CCR5, CXCR4 and intracellular expression of Foxp3, HIVp24, IFN-g and Bcl-2. T-reg purified by immunomagnetic bead separation were assessed for HIV-1 strong stop (SS) DNA expression by real-time PCR.
Results: High numbers of T-reg (defined as CD4
+
Foxp3
+ or CD4
, that were HIV-1-infected were found in PFMC. T-reg displayed higher expression of the cellular activation marker, HLA-DR (p<0.001), and HIV-1 co-receptors (CCR5 and CXCR4) (p<0.05 for both) as compared to non-T-reg. Purified T-reg exhibited higher HIV-1 infection, as measured by HIV-1 SS DNA, when compared to whole PFMC, and as compared to PFMC T-reg from an HIV-infected subject with mesothelioma. HIV-infected CD4 + Foxp3 + T-reg were significantly higher in Bcl-2 expression as compared to CD4 + Foxp3 -cells (p<0.001). Further, HIV-1-infected T-reg showed significantly higher Bcl-2 reactivity than un-infected T-reg (p<0.001). A small fraction of HIV-1-infected T-reg were also IFN-g + .
Conclusion:
At sites of pleural HIV/TB infection higher frequencies of PFMC T-reg with survival advantage are predisposed to productive HIV-1 infection as compared to non-T-reg.
blood mononuclear cells [16, 17] . Also, naive T-cell precursors of Foxp3 positive T-reg are susceptible to HIV infection in vitro [18] . Both heightened status of cellular activation [19] and increased expression of HIV-1 co-receptors [17] may underlie predisposition of T-reg to successful viral infection. Further, Foxp3 enhances NFкb occupancy at HIV-1 LTR [20] , indicating that T-reg are predisposed to productive HIV-1 infection. However, others have shown that transfection of Foxp3 gene in CD4 T cells in fact represses HIV-1 transcription [21, 22] . Therefore, the transcriptional basis of HIV-1 infection in T-reg remains controversial.
Other studies have shown that CD4 + Foxp3 + T-cells express IFN-g, when activated under a Th1 cytokine polarizing environment [23, 24] , and a Th1 cytokine milieu characterizes sites of pleural TB [6, 25] . Expression of IFN-g among T-reg during HIV/TB co-infection is not known.
Based on our previous observations of both enhanced HIV activity and increased frequencies of T-reg at pleural sites of HIV/ TB we hypothesized that T-reg expanded at pleural sites of dual HIV/ TB infection may directly contribute to expansion of HIV-1 activity. We found that among CD4+ T-cells in PFMC, HIV-1 infection was enriched in the CD4 
Methods
Study subjects
Patients hospitalized at Mulago Hospital at Makerere University in Kampala Uganda with symptoms of fever, cough, night sweats, dyspnea for at least 2 weeks who had moderate to large pleural effusion were identified and referred to the TB clinic of the TB Research Unit for evaluation of pleural TB. Informed consent (approved by the Institutional Review Board at CWRU and the Ugandan National AIDS Research Subcommittee) was obtained from all subjects. All patients underwent HIV-1 testing, and thoracocentesis and pleural biopsy as previously described [26] . Diagnosis of pleural TB was based on positive culture of sputum and/or pleural fluid, and/or positive histology of pleural tissue for MTB. Only HIV + patients were included in this study (n=16). All patients received standard shortcourse anti-TB therapy and were followed as before. Table 1 describes the characteristics of enrolled patients.
Preparation of cells and separation of T-reg from PFMC using magnetic beads
PFMC were prepared by FicollHypaque (Pharmacia Fine Chemicals, Piscataway, NJ) density gradient centrifugation as described [26] . Viability was >98% as assessed by trypan blue exclusion. By immmunostaining and FACS analysis PFMC were 40-60% CD4 T-cells and contained only 1-5% CD14 + macrophages.
In a few experiments, T-reg were prepared by magnetic bead separation of PFMC using the Human regulatory T-cell isolation kit II from Miltenyi Biotech (Auburn, CA) as instructed by the manufacturer. Purity of CD4 
Analysis of cell phenotype by flow cytometry
At the onset of study 4 color flow cytometry was used, as this was the limit of the flow cytometer available on site. Antibody and isotype control antibody combinations used to characterize T-reg included: 1. CD4 PercpCy5.5, HLA-DR APC, CD127 Pac Blue and rat FoxP3 PE; 2. CD4 PercpCy5.5, IgG2a APC, IgG1 Pac Blue and rat IgG2a PE (all from eBioscience, San Diego, CA); 3. CD4 PercpCy5, CCR5 FITC, CXCR4 APC (both from Biolegend, San Diego, CA) and Foxp3 PE; 4.CD4 PercpCy5, IgG2a FITC, rat IgG2a APC and rat IgG2a PE; 5. CD4 PercpCy5, p24 FITC (Beckman Coulter, Brea, CA), Bcl-2 PE(BD Biosciences, San Jose, CA) and FoxP3 e-fluor660; 6.CD4 PercpCy5, IgG1 FITC, IgG1 PE and rat IgG2a e-fluor660 (eBioscience).
Subsequently, a MiltenyiMACSQuant Flow cytometer (allowing for the assessment of samples containing a maximum of 8 fluorochromes) became available. To assure that staining with FoxP3 antibody alone accurately identifies T-reg, subsequently duplicate samples for each patient were stained with CD127 Pac Blue (or IgG1 isotype antibody in combination with FoxP3 PE or Foxp3 alone (as above). We chose CD127 as an additional marker for T-reg as studies by Fazekas et al. and Seddiqui et al. [27, 28] indicate that addition of CD127 to Foxp3 and/or CD25 allows for the identification and isolation of a pure population of T-reg and allows for a better discrimination between T-reg and activated (CD25 + ) T-cells. We established that a strong correlation between frequencies of T-reg characterized as CD4 The protocol and buffer set from eBioscience were used for all experiments involving intracellular staining. Samples were fixed and acquired within 1h of completion of staining. Data were analyzed in bulk using FlowJo software (TreestarInc, Ashland, OR) at the completion of study.
Measurement HIV-1 DNA by real-time PCR
Cellular DNA was extracted from the lower phase of cell lysates in Tri-reagent according to the manufacturer's instructions. Real time PCR using the Taqman methodology by ABI StepONEPlusthermo cycler (Applied Biosystems, Foster City, CA)was performed for HIV-1 minus-strand strong stop (SS) DNA (which represents HIV-1 transcripts post-cell entry that have initiated reverse transcription) [29] , and human beta globin DNA. In each sample DNA copies were normalized to the copy number of beta globin (0·5×10 10 copies in 1 million cells).
Statistics
Normally distributed data sets were analyzed by student t-test. Wilcoxon or Kruskall Wallis tests were used for data sets that were not normally distributed. Correlation between variables was assessed using linear regression and correlation or spearman rank order correlation as appropriate. P ≤ 0.05 was considered significant 
Results
Foxp3
-PFMC. Figure 2A shows these results: expression of both CCR5 and CXCR4 was higher on CD4 +
+ as compared to CD4 +
-T-cells (P<0.01 for both comparisons, n=5).
To confirm enrichment of HIV infection among PFMC T-reg, whole PFMC and T-reg (CD4 +
Foxp3
+ CD127 -) purified by immunomagnetic separation were compared. Cellular DNA was assessed by HIV-1 strong stop (SS) DNA (HIV-1 transcripts that have initiated reverse transcription). Results from two HIV/TB subjects were compared to PFMC and T-reg obtained from an HIVinfected subject with pleural mesothelioma. HIV-1 SS DNA was enriched among PFMC T-reg as compared to whole PFMC in HIV/ TB subjects ( Figure 2B ). HIV-1SSDNA in PFMC from the subject with mesothelioma was low and not enriched in their T-reg.
HIV infected Foxp3 + T reg cells have survival advantage among PFMC
Previously we have observed a survival advantage (by Tunel assay) of T-reg over non-T-reg among PFMC in HIV/TB co-infected subjects (unpublished data). Here, the intracellular co-expression of Bcl-2 and HIV-1 p24 among CD4 
Foxp3
-PFMC.
PFMC from HIV/TB patients were assessed for CD4, Foxp3 + , and the HIV-1 co-receptors CCR5 and CXCR4. Expression of CCR5 and CXCR4 was increased in CD4
+
Foxp3
+ T-reg as compared to CD4
+
Foxp3
-PFMC (P<0.01 for both, n=5) (A). HIV-1 entry was assessed by PCR following immunomagnetic separation of PFMC to obtain T-reg (CD4
+
Foxp3
+ CD127 -) and compared to that in whole PFMC. Results shown are for 2 HIV/TB patients and one HIV infected subject with pleural mesothelioma (B). 
HIV p24
-CD4 T-cell subsets were determined by simultaneous staining with antibody to Bcl-2 (n=16).
progression through viral production. This is in addition to the role of T-reg in suppression of antigen-specific CD4 and CD8 anti HIV-1 T-cell responses [30] . Here we found significantly higher numbers of T-reg defined as CD4 +
Foxp3
+ CD127
that were HIV-1 infected in PFMC at sites of pleural HIV/TB. T-reg were characterized by both significantly higher cellular activation (HLA-DR) and expression of HIV-1 co-receptors (CCR5 and CXCR4) as compared to non-Treg, underscoring their susceptibility to productive HIV-1 infection. Interestingly, HIV-1 infected T-reg were Bcl-2 reactive, implicating their survival advantage not only over non-T-reg, but also over HIVuninfected T-reg. Also, a significantly greater fraction of T-reg were both HIV-1 infected and IFN-g + , when compared to non-T-reg. Cumulatively, these data pose T-reg as a dominant HIV-infected CD4 T-cell population with survival advantage at sites of TB. Whether increased frequencies of HIV-infected T-reg directly contribute to HIV production at sites of HIV/TB through HIV release or infection of other mononuclear cells needs to be established in future studies.
During in vitro infection of T-cells by either HIV-1 [17, 18] or FIV [31] , T-reg support higher viral replication than non-T-reg. Both degree of HIV-1 co-receptor expression and activation status determines successful productive HIV-1 infection of mononuclear cells. Previously, we had found higher expression of both CCR5 [29] and CXCR4 (unpublished) by CD4 T-cells in PFMC from dually infected HIV/TB subjects. Here we identify CD4 In the current study, we found more PFMC T-reg that were dually positive for HIV-1 p24 and Bcl-2 than non-T-reg. Even among T-reg, HIV infection was associated with significantly higher expression of Bcl-2. Therefore, HIV-1 infected T-reg at sites of HIV-1/TB are presumably characterized by lesser predisposition to apoptosis as compared to other T-cells. However, others have shown that among Foxp3 targeted genes in iT-reg, expression of Bcl-2 is actually downregulated [32] , and inhibition of Bcl-2 expression appears to be based on interaction of Foxp3 with the transcriptional repressor, Eos [33] . While it is possible that at sites of HIV/TB, interaction of Foxp3 and Eos is defective in PFMC T-reg, this needs to be investigated. On the other hand, TCR engagement leads to expression of antiapoptotic molecules Bcl-2, Bfl-1 and Bcl-xl in T-cells [34, 35] . Strong Th1signaling provided at sites of HIV/TB infection [6, 25] , in the presence of continuous TGF-β signaling necessary in maintaining Foxp3 expression [36] , likely underlies the basis of expanded Bcl-2 This may explain the correlation of PFMC Foxp3 mRNA to viral load in the pleural fluid of HIV/TB patients found here (data not shown, n=16, r=0.780, p<0.002). Of note, however, there was only a modest and insignificant correlation of Foxp3 mRNA expression in PFMC with pleural fluid viral load in our previous study (n=10, r=0.5) [6] .
Recently, it has been shown that CD4 +
+ T-cells can produce IFN-g when activated under a Th1 cytokine polarizing environment [23, 24] . In fact, it has been suggested that IFN-g production identifies pathogen epitope-specific T-reg during viral infections [37] . Here, up to 6.1% of T-reg (CD4 [38] . However, the true role of IFN-g producing T-reg at sites of dual HIV/ TB remains to be deciphered. In summary, higher frequencies of T-reg as compared to non-Treg are HIV-infected and display survival advantage among PFMC at sites of pleural HIV/TB. Whether expanded T-reg at sites of dual HIV/ TB infection contribute to HIV-1 viral activity also by undermining anti-HIV-1 immune responses of CD4 and CD8 effector T-cells needs to be further studied.
